Witold Zatoński
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Witold Zatoński has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Peter Boyle
International Prevention Research Institute (IPRI), Lyon, France
3 shared publications - Piotr Tutka
Department of Experimental and Clinical Pharmacology, University of Rzeszów, Kopisto 2a, 35-959 Rzeszów, Poland
3 shared publications - Andrzej Wojtyła
Inst Rural Hlth, Dept Hlth Promot Food & Nutr, PL-20090 Lublin, Poland
2 shared publications - Iwona Bojar
Department of Women's Health, Institute of Rural Health in Lublin, Lublin, Poland
2 shared publications - Jerzy Tadeusz Marcinkowski
Department of Hygiene, Poznan University of Medical Sciences, Poznan, Poland
2 shared publications - John Powles
Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
2 shared publications
Latest Publications
- Open Access
- 13 June 2018
- Published by European Publishing in Tobacco Prevention & Cessation
- Vol. 4 (Supplement)
Rapid decline in cigarette smoking among children in Poland
- 13 June 2018
- Published by European Publishing in Tobacco Prevention & Cessation
- Vol. 4 (Supplement)
Open AccessRapid decline in cigarette smoking among children in Poland
- 1 January 2016
- Published by Termedia Sp. z.o.o. in Journal of Health Inequalities
- Vol. 1, 32-35
The significance and impact of the Polish Anti-tobacco Law
By the end of the 1980s Poland was at the brink of a health catastrophe. Cardiovascular diseases and lung cancer mortality steadily increased and were among the highest ever observed in the world. Life expectancy for young adult and middle aged men reached levels similar to China and India. The...
- 1 January 2016
- Published by Termedia Sp. z.o.o. in Journal of Health Inequalities
- Vol. 1, 32-35
The significance and impact of the Polish Anti-tobacco Law
By the end of the 1980s Poland was at the brink of a health catastrophe. Cardiovascular diseases and lung cancer mortality steadily increased and were among the highest ever observed in the world. Life expectancy for young adult and middle aged men reached levels similar to China and India. The...
- 1 January 2016
- Published by European Publishing in Tobacco Prevention & Cessation
- Vol. 2 (April Supp)
Lung cancer and smoking among women – a new challenge in Europe
- 1 January 2016
- Published by European Publishing in Tobacco Prevention & Cessation
- Vol. 2 (April Supp)
Lung cancer and smoking among women – a new challenge in Europe
- 1 March 2012
- Published by Elsevier in Public Health
- Vol. 126 (3) , 248-252
Changing trends of diseases in Eastern Europe: Closing the gap
- 1 March 2012
- Published by Elsevier in Public Health
- Vol. 126 (3) , 248-252
Changing trends of diseases in Eastern Europe: Closing the gap
- 1 January 2011
- Vol. 18 (1) , 169-74
Nutritional behaviours among pregnant women from rural and urban environments in Poland.
Based on data obtained from the system MoZMaD - PL (Polish Mother and Child Health Monitoring System); an equivalent of the American system PRAMS (Pregnancy Risk Assessment Monitoring System). The health behaviour of a pregnant woman, including adequate nutritional behaviours and supply of all the necessary nutrients, exert an effect on the health of a woman, development of the foetus, and the occurrence of diseases among the offspring at the age of maturity. The objective of the study was analysis of the nutritional behaviours among Polish pregnant women, with particular consideration of the recognition of dietary changes caused by the fact of becoming pregnant. The studies were based on questionnaire forms within the Polish Mother and Child Heath Monitoring System (MoZMaD - PL) implemented in Poland. The precise day of studies is appointed annually for the whole of Poland by the Chief Sanitary Inspector. The questionnaire forms were correctly completed in 2010 by 2,877 women. The replies to the questions were introduced by surveyors into the MoZMaD - PL system, a central database managed by the Institute of Agricultural Medicine. The results obtained were subjected to statistical analysis. More than a half of Polish women change their diet in pregnancy. According to the pregnant women examined, the changes in their diet consist in a more frequent consumption of white meat, fish, fruits and vegetables, as well as milk and dairy products. Favourable changes in diet were observed primarily among the respondents from the urban environment. Considering an insufficient awareness with respect to nutritional behaviours among females at reproductive age, the education of pregnant women and those who plan a pregnancy concerning an adequate diet should be jointly conducted by medical circles, schools, and the media, and directed primarily to women from the rural environment.
- 1 January 2011
- Vol. 18 (1) , 169-74
Nutritional behaviours among pregnant women from rural and urban environments in Poland.
Based on data obtained from the system MoZMaD - PL (Polish Mother and Child Health Monitoring System); an equivalent of the American system PRAMS (Pregnancy Risk Assessment Monitoring System). The health behaviour of a pregnant woman, including adequate nutritional behaviours and supply of all the necessary nutrients, exert an effect on the health of a woman, development of the foetus, and the occurrence of diseases among the offspring at the age of maturity. The objective of the study was analysis of the nutritional behaviours among Polish pregnant women, with particular consideration of the recognition of dietary changes caused by the fact of becoming pregnant. The studies were based on questionnaire forms within the Polish Mother and Child Heath Monitoring System (MoZMaD - PL) implemented in Poland. The precise day of studies is appointed annually for the whole of Poland by the Chief Sanitary Inspector. The questionnaire forms were correctly completed in 2010 by 2,877 women. The replies to the questions were introduced by surveyors into the MoZMaD - PL system, a central database managed by the Institute of Agricultural Medicine. The results obtained were subjected to statistical analysis. More than a half of Polish women change their diet in pregnancy. According to the pregnant women examined, the changes in their diet consist in a more frequent consumption of white meat, fish, fruits and vegetables, as well as milk and dairy products. Favourable changes in diet were observed primarily among the respondents from the urban environment. Considering an insufficient awareness with respect to nutritional behaviours among females at reproductive age, the education of pregnant women and those who plan a pregnancy concerning an adequate diet should be jointly conducted by medical circles, schools, and the media, and directed primarily to women from the rural environment.
- 1 January 2011
- Vol. 18 (1) , 183-8
Prevention of female reproductive system cancer among rural and urban Polish pregnant women.
Based on data obtained from the system MoZMaD - PL (Polish Mother and Child Health Monitoring System; an equivalent of the American system PRAMS (Pregnancy Risk Assessment Monitoring System). In the developed countries prevention programmes proved to be efficient in reducing morbidity and mortality due to breast and cervical cancer. In Poland, these diseases still constitute a very big problem, despite relatively easy and early diagnostics of pathological conditions preceding their development. The objective of the study was analysis of the usage of prophylactic examinations and the assessment of knowledge concerning risk factors of the development of reproductive cancers among pregnant women from rural and urban environments in Poland. The study was based on questionnaire forms within the Pregnancy Risk Assessment Monitoring System (MoZMaD - PL) implemented in Poland. The precise date of the study for the whole of Poland is announced annually by the Chief Sanitary Inspector. The questionnaire forms were correctly completed in 2010 by 2,877 women. The replies to the questions were introduced by surveyors into the MoZMaD - PL system central database managed by the Institute of Agricultural Medicine in Lublin. The results obtained were subjected to statistical analysis. The studies of pregnant women in Poland showed that the situation with respect to the performance of prevention examinations for cervical cancer was significantly worse among rural than urban women. Pregnant women from both rural and urban areas very rarely had breast USG performed. Awareness concerning cervical cancer risk factors was lower among rural than urban women. Also, knowledge concerning the examinations which should be performed for the prevention of breast cancer was poorer among rural, compared to urban women. The recognition of the attitudes of women at reproductive age towards prevention examinations is necessary in order to effectively plan health education and social health promotion campaigns aimed at limiting morbidity and mortality due to cancerous diseases.
- 1 January 2011
- Vol. 18 (1) , 183-8
Prevention of female reproductive system cancer among rural and urban Polish pregnant women.
Based on data obtained from the system MoZMaD - PL (Polish Mother and Child Health Monitoring System; an equivalent of the American system PRAMS (Pregnancy Risk Assessment Monitoring System). In the developed countries prevention programmes proved to be efficient in reducing morbidity and mortality due to breast and cervical cancer. In Poland, these diseases still constitute a very big problem, despite relatively easy and early diagnostics of pathological conditions preceding their development. The objective of the study was analysis of the usage of prophylactic examinations and the assessment of knowledge concerning risk factors of the development of reproductive cancers among pregnant women from rural and urban environments in Poland. The study was based on questionnaire forms within the Pregnancy Risk Assessment Monitoring System (MoZMaD - PL) implemented in Poland. The precise date of the study for the whole of Poland is announced annually by the Chief Sanitary Inspector. The questionnaire forms were correctly completed in 2010 by 2,877 women. The replies to the questions were introduced by surveyors into the MoZMaD - PL system central database managed by the Institute of Agricultural Medicine in Lublin. The results obtained were subjected to statistical analysis. The studies of pregnant women in Poland showed that the situation with respect to the performance of prevention examinations for cervical cancer was significantly worse among rural than urban women. Pregnant women from both rural and urban areas very rarely had breast USG performed. Awareness concerning cervical cancer risk factors was lower among rural than urban women. Also, knowledge concerning the examinations which should be performed for the prevention of breast cancer was poorer among rural, compared to urban women. The recognition of the attitudes of women at reproductive age towards prevention examinations is necessary in order to effectively plan health education and social health promotion campaigns aimed at limiting morbidity and mortality due to cancerous diseases.
- Open Access
- 3 January 2008
- Published by Springer Nature in BMC Public Health
- Vol. 8 (1) , 2
The relationship between smokers' motivation to quit and intensity of tobacco control at the population level: a comparison of five European countries
Smoking prevalence differs significantly across Europe. In addition, there are considerable differences in tobacco control activities across European countries. The relationship between prevalence and policy is under-researched. The present analysis examines the motivation to change smoking behaviour across 5 different European countries that differ considerably in their tobacco control activities. A population-based, representative survey of 1750 smokers, aged 16–59, from 5 different European countries (Germany, Greece, Poland, Sweden, UK) was used. Demographic variables, smoking status and the motivation to stop smoking were assessed. Motivation was assessed as, first, intending to quit (using the stages of change plus a modified stage for Precontemplation), and second, the desire to quit. The majority of smokers want to stop smoking (73.5%), while only 35.0% want to stop definitely. Across countries, 10.2% definitely do not want to stop. Most of the smokers can be categorised in the Precontemplation stage (between 62.6% and 77.7% depending on the country), one of the stages of change categories. The relationship between the stages of change and the country under examination is statistically significant (chi-square = 43.466, p < 0.001). In countries with a high level of tobacco control, the proportion of people in Precontemplation is lower than in countries with low tobacco control activity. There are differences in the stages of change between the countries under examination. However, the categorisation of the countries into low, medium and high tobacco control activity used in this analysis does not explain these differences. Most smokers want to stop smoking, but a high proportion cannot indicate a time-frame when this is going to happen. Tobacco control efforts or other kinds of support might encourage these smokers to actually try to stop. Longitudinal studies at the population level are needed to assess, relate or monitor tobacco control activities and the intention to stop.
- 3 January 2008
- Published by Springer Nature in BMC Public Health
- Vol. 8 (1) , 2
Open AccessThe relationship between smokers' motivation to quit and intensity of tobacco control at the population level: a comparison of five European countries
Smoking prevalence differs significantly across Europe. In addition, there are considerable differences in tobacco control activities across European countries. The relationship between prevalence and policy is under-researched. The present analysis examines the motivation to change smoking behaviour across 5 different European countries that differ considerably in their tobacco control activities. A population-based, representative survey of 1750 smokers, aged 16–59, from 5 different European countries (Germany, Greece, Poland, Sweden, UK) was used. Demographic variables, smoking status and the motivation to stop smoking were assessed. Motivation was assessed as, first, intending to quit (using the stages of change plus a modified stage for Precontemplation), and second, the desire to quit. The majority of smokers want to stop smoking (73.5%), while only 35.0% want to stop definitely. Across countries, 10.2% definitely do not want to stop. Most of the smokers can be categorised in the Precontemplation stage (between 62.6% and 77.7% depending on the country), one of the stages of change categories. The relationship between the stages of change and the country under examination is statistically significant (chi-square = 43.466, p < 0.001). In countries with a high level of tobacco control, the proportion of people in Precontemplation is lower than in countries with low tobacco control activity. There are differences in the stages of change between the countries under examination. However, the categorisation of the countries into low, medium and high tobacco control activity used in this analysis does not explain these differences. Most smokers want to stop smoking, but a high proportion cannot indicate a time-frame when this is going to happen. Tobacco control efforts or other kinds of support might encourage these smokers to actually try to stop. Longitudinal studies at the population level are needed to assess, relate or monitor tobacco control activities and the intention to stop.
- Open Access
- 5 April 2007
- Published by Springer Nature in BMC Cancer
- Vol. 7 (1) , 1-7
Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study
The sex hormone-binding globulin (SHBG) is a carrier protein that modulates the bio-availability of serum sex steroid hormones, which may be involved in ovarian cancer. We evaluated whether common genetic variation in SHBG and its 3' neighbor ATP1B2, in linkage disequilibrium, is associated with the risk of epithelial ovarian cancer. The study population included 264 women with ovarian carcinoma and 625 controls participating in a population-based case-control study in Poland. Five common single nucleotide polymorphisms (SNPs) in SHGB and five in ATP1B2 were selected to capture most common variation in this region. None of the SNPs evaluated was significantly associated with ovarian cancer risk, including the putative functional SNPs SHBG D356N (rs6259) and -67G>A 5'UTR (rs1799941). However, our data were consistent with a decreased ovarian cancer risk associated with the variant alleles for these two SNPs, which have been previously associated with increased circulating levels of SHBG. These data do not support a substantial association between common genetic variation in SHBG and ovarian cancer risk.
- 5 April 2007
- Published by Springer Nature in BMC Cancer
- Vol. 7 (1) , 1-7
Open AccessOvarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study
The sex hormone-binding globulin (SHBG) is a carrier protein that modulates the bio-availability of serum sex steroid hormones, which may be involved in ovarian cancer. We evaluated whether common genetic variation in SHBG and its 3' neighbor ATP1B2, in linkage disequilibrium, is associated with the risk of epithelial ovarian cancer. The study population included 264 women with ovarian carcinoma and 625 controls participating in a population-based case-control study in Poland. Five common single nucleotide polymorphisms (SNPs) in SHGB and five in ATP1B2 were selected to capture most common variation in this region. None of the SNPs evaluated was significantly associated with ovarian cancer risk, including the putative functional SNPs SHBG D356N (rs6259) and -67G>A 5'UTR (rs1799941). However, our data were consistent with a decreased ovarian cancer risk associated with the variant alleles for these two SNPs, which have been previously associated with increased circulating levels of SHBG. These data do not support a substantial association between common genetic variation in SHBG and ovarian cancer risk.
- 16 January 2007
- Vol. 58 (6) , 777-98
Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy.
Cytisine, a natural plant alkaloid, has been marketed in Central and Eastern Europe for over 40 years for the clinical management of smoking cessation. Despite the fact that cytisine has been used by millions of smokers, its characteristics have not been reviewed in scientific literature in English, and presently existing clinical studies on its effectiveness and safety are insufficient to warrant licensing by modern standards. Understanding of the mechanism of cytisine action as a smoking cessation aid provides a necessary basis for conducting clinical trials to confirm its efficacy as an optimal antismoking therapy. Hereafter, we present a review of current knowledge about the pharmacokinetics, pharmacodynamics, toxicity, therapeutic efficacy and safety of cytisine, and about its derivatives that are under development. Recent pharmacological research has elucidated that the drug is a low efficacy partial agonist of alpha4beta2 nicotinic acetylcholine receptors, which are believed to be central to the effect of nicotine (NIC) on the reward pathway. The drug reduces the effects of NIC on dopamine release in the mesolimbic system when given alone, while simultaneously attenuating NIC withdrawal symptoms that accompany cessation attempts. Clinical studies on cytisine as a smoking cessation aid have demonstrated that the drug is effective and safe. Our recent uncontrolled trial has shown that a 12-month carbon monoxide-verified continuous abstinence rate following a standard course of treatment with cytisine with minimal behavioral support is similar (13.8%; N = 436) to that observed following treatment with NIC replacement therapy. Since cytisine exhibits a desirable pharmacological profile which makes it an attractive smoking cessation drug, it should be advanced to randomized clinical trials. However, more detailed preclinical studies on its pharmacokinetics and safety profile are required.
- 16 January 2007
- Vol. 58 (6) , 777-98
Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy.
Cytisine, a natural plant alkaloid, has been marketed in Central and Eastern Europe for over 40 years for the clinical management of smoking cessation. Despite the fact that cytisine has been used by millions of smokers, its characteristics have not been reviewed in scientific literature in English, and presently existing clinical studies on its effectiveness and safety are insufficient to warrant licensing by modern standards. Understanding of the mechanism of cytisine action as a smoking cessation aid provides a necessary basis for conducting clinical trials to confirm its efficacy as an optimal antismoking therapy. Hereafter, we present a review of current knowledge about the pharmacokinetics, pharmacodynamics, toxicity, therapeutic efficacy and safety of cytisine, and about its derivatives that are under development. Recent pharmacological research has elucidated that the drug is a low efficacy partial agonist of alpha4beta2 nicotinic acetylcholine receptors, which are believed to be central to the effect of nicotine (NIC) on the reward pathway. The drug reduces the effects of NIC on dopamine release in the mesolimbic system when given alone, while simultaneously attenuating NIC withdrawal symptoms that accompany cessation attempts. Clinical studies on cytisine as a smoking cessation aid have demonstrated that the drug is effective and safe. Our recent uncontrolled trial has shown that a 12-month carbon monoxide-verified continuous abstinence rate following a standard course of treatment with cytisine with minimal behavioral support is similar (13.8%; N = 436) to that observed following treatment with NIC replacement therapy. Since cytisine exhibits a desirable pharmacological profile which makes it an attractive smoking cessation drug, it should be advanced to randomized clinical trials. However, more detailed preclinical studies on its pharmacokinetics and safety profile are required.